4.7 Review

Epigenetic Treatments for Cognitive Impairments

Journal

NEUROPSYCHOPHARMACOLOGY
Volume 37, Issue 1, Pages 247-260

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/npp.2011.85

Keywords

learning and memory; neurodegeneration; neuroprotection; drug discovery; development; epigenetics

Funding

  1. NINDS
  2. NIMH
  3. NIA
  4. NIDA
  5. Rett Syndrome Foundation
  6. Ellison Medical Foundation
  7. Evelyn F McKnight Brain Research Foundation

Ask authors/readers for more resources

Epigenetic mechanisms integrate signals from diverse intracellular transduction cascades and in turn regulate genetic readout. Accumulating evidence has revealed that these mechanisms are critical components of ongoing physiology and function in the adult nervous system, and are essential for many cognitive processes, including learning and memory. Moreover, a number of psychiatric disorders and syndromes that involve cognitive impairments are associated with altered epigenetic function. In this review, we will examine how epigenetic mechanisms contribute to cognition, consider how changes in these mechanisms may lead to cognitive impairments in a range of disorders and discuss the potential utility of therapeutic treatments that target epigenetic machinery. Finally, we will comment on a number of caveats associated with interpreting epigenetic changes and using epigenetic treatments, and suggest future directions for research in this area that will expand our understanding of the epigenetic changes underlying cognitive disorders. Neuropsychopharmacology Reviews (2012) 37, 247-260; doi: 10.1038/npp.2011.85; published online 18 May 2011

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available